Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 18, 2013 - Issue 2
Submit an article Journal homepage
495
Views
21
CrossRef citations to date
0
Altmetric
Reviews

Update on bevacizumab and other angiogenesis inhibitors for brain cancer

Mikael L RinneDana-Farber/Brigham and Women's Cancer Center, Center for Neuro-Oncology, Boston, MA, USA;Brigham and Women's Hospital, Division of Neuro-Oncology, Department of Neurology, Boston, MA, USA
,
Eudocia Q LeeDana-Farber/Brigham and Women's Cancer Center, Center for Neuro-Oncology, Boston, MA, USA;Brigham and Women's Hospital, Division of Neuro-Oncology, Department of Neurology, Boston, MA, USA
,
Lakshmi NayakDana-Farber/Brigham and Women's Cancer Center, Center for Neuro-Oncology, Boston, MA, USA;Brigham and Women's Hospital, Division of Neuro-Oncology, Department of Neurology, Boston, MA, USA
,
Andrew D NordenDana-Farber/Brigham and Women's Cancer Center, Center for Neuro-Oncology, Boston, MA, USA;Brigham and Women's Hospital, Division of Neuro-Oncology, Department of Neurology, Boston, MA, USA
,
Rameen BeroukhimDana-Farber/Brigham and Women's Cancer Center, Center for Neuro-Oncology, Boston, MA, USA;Dana-Farber Cancer Institute and Brigham and Women's Hospital, Center for Neuro-Oncology, Department of Medical Oncology, 450 Brookline Avenue, SW460F, Boston, MA 02215-5450, USA+1 617 632 2166; +1 617 632 3352; [email protected]
,
Patrick Y WenDana-Farber/Brigham and Women's Cancer Center, Center for Neuro-Oncology, Boston, MA, USA;Brigham and Women's Hospital, Division of Neuro-Oncology, Department of Neurology, Boston, MA, USA
&
David A ReardonDana-Farber/Brigham and Women's Cancer Center, Center for Neuro-Oncology, Boston, MA, USA;Dana-Farber Cancer Institute and Brigham and Women's Hospital, Center for Neuro-Oncology, Department of Medical Oncology, 450 Brookline Avenue, SW460F, Boston, MA 02215-5450, USA+1 617 632 2166; +1 617 632 3352; [email protected]
, MD show all
Pages 137-153 | Published online: 14 May 2013

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yu-Long Lan, Zhen-Long Yu, Jia-Cheng Lou, Xiao-Chi Ma & Bo Zhang. (2018) Update on the effects of the sodium pump α1 subunit on human glioblastoma: from the laboratory to the clinic. Expert Opinion on Investigational Drugs 27:9, pages 753-763.
Read now

Articles from other publishers (20)

S. Sriharikrishnaa, Padmanaban S. Suresh & Shama Prasada K.. 2023. Optical Polarimetric Modalities for Biomedical Research. Optical Polarimetric Modalities for Biomedical Research 307 330 .
Amir R. Afshari, Mehdi Sanati, Samaneh Aminyavari, Farzaneh Shakeri, Bahram Bibak, Zakieh Keshavarzi, Mohammad Soukhtanloo, Mohammad Jalili-Nik, Mohammad Montazami Sadeghi, Hamid Mollazadeh, Thomas P. Johnston & Amirhossein Sahebkar. (2022) Advantages and drawbacks of dexamethasone in glioblastoma multiforme. Critical Reviews in Oncology/Hematology 172, pages 103625.
Crossref
Aleksandr V. Sokolov, Samira A. Dostdar, Misty M. Attwood, Aleksandra A. Krasilnikova, Anastasia A. Ilina, Amina Sh. Nabieva, Anna A. Lisitsyna, Vladimir N. Chubarev, Vadim V. Tarasov & Helgi B. Schiöth. (2022) Brain Cancer Drug Discovery: Clinical Trials, Drug Classes, Targets, and Combinatorial Therapies. Pharmacological Reviews 73:4, pages 1172-1203.
Crossref
Daniel Dubinski, Elke Hattingen, Christian Senft, Volker Seifert, Kevin G Peters, Yvonne Reiss, Kavi Devraj & Karl H Plate. (2019) Controversial roles for dexamethasone in glioblastoma – Opportunities for novel vascular targeting therapies. Journal of Cerebral Blood Flow & Metabolism 39:8, pages 1460-1468.
Crossref
Eloisi Caldas-Lopes, Alexandra Gomez-Arteaga & Monica L. Guzman. (2019) Approaches to Targeting Cancer Stem Cells in Solid Tumors. Current Stem Cell Research & Therapy 14:5, pages 421-427.
Crossref
Deok-Hoon Kong, Mi Kim, Ji Jang, Hee-Jun Na & Sukmook Lee. (2017) A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy. International Journal of Molecular Sciences 18:8, pages 1786.
Crossref
Lars G. J. Hammarström, Robert K. Harmel, Mikael Granath, Rune Ringom, Ylva Gravenfors, Katarina Färnegårdh, Per H. Svensson, David Wennman, Göran Lundin, Ylva Roddis, Satish S. Kitambi, Alexandra Bernlind, Fredrik Lehmann & Patrik Ernfors. (2016) The Oncolytic Efficacy and in Vivo Pharmacokinetics of [2-(4-Chlorophenyl)quinolin-4-yl](piperidine-2-yl)methanol (Vacquinol-1) Are Governed by Distinct Stereochemical Features. Journal of Medicinal Chemistry 59:18, pages 8577-8592.
Crossref
Emilie George, Allison Settler, Scott Connors & Jeffrey P. Greenfield. (2015) Pediatric Gliomatosis Cerebri: A Review of 15 Years. Journal of Child Neurology 31:3, pages 378-387.
Crossref
Mette Kjoelhede Nedergaard, Signe Regner Michaelsen, Lara Perryman, Janine Erler, Hans Skovgaard Poulsen, Marie-Thérése Stockhausen, Ulrik Lassen & Andreas Kjaer. (2016) Comparison of 18F-FET and 18F-FLT small animal PET for the assessment of anti-VEGF treatment response in an orthotopic model of glioblastoma. Nuclear Medicine and Biology 43:3, pages 198-205.
Crossref
Valerie Albrecht, Antonia Richter, Sarah Pfeiffer, Michaela Gebauer, Simon Lindner, Eugenie Gieser, Ulrich Schüller, Christian Schichor, Franz Josef Gildehaus, Peter Bartenstein, Jörg-Christian Tonn, Arne Skerra & Rainer Glass. (2016) Anticalins directed against the fibronectin extra domain B as diagnostic tracers for glioblastomas. International Journal of Cancer 138:5, pages 1269-1280.
Crossref
Rong Shao, Sherry L. Taylor, Dennis S. Oh & Lawrence M. Schwartz. (2015) Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization. Oncotarget 6:38, pages 40507-40518.
Crossref
Susanne Grube, Tatjana Göttig, Diana Freitag, Christian Ewald, Rolf Kalff & Jan Walter. (2015) Selection of suitable reference genes for expression analysis in human glioma using RT-qPCR. Journal of Neuro-Oncology 123:1, pages 35-42.
Crossref
Surim Park, Jong Won Kim, Jong Hoon Kim, Chae Woong Lim & Bumseok Kim. (2015) Differential Roles of Angiogenesis in the Induction of Fibrogenesis and the Resolution of Fibrosis in Liver. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 38:7, pages 980-985.
Crossref
Zili Zhang, Feng Zhang, Yin Lu & Shizhong Zheng. (2015) Update on implications and mechanisms of angiogenesis in liver fibrosis. Hepatology Research 45:2, pages 162-178.
Crossref
Maxim A. Shevtsov, Boris P. Nikolaev, Ludmila Y. Yakovleva, Anatolii V. Dobrodumov, Alexander V. Zhakhov, Anastasiy L. Mikhrina, Emil Pitkin, Marina A. Parr, Valerii I. Rolich, Andrei S. Simbircev & Alexander M. Ischenko. (2015) Recombinant Interleukin-1 Receptor Antagonist Conjugated to Superparamagnetic Iron Oxide Nanoparticles for Theranostic Targeting of Experimental Glioblastoma. Neoplasia 17:1, pages 32-42.
Crossref
Brian Stagg, Hironori Uehara, Nathan Lambert, Ruju Rai, Isha Gupta, Bryce Radmall, Taylor Bates & Balamurali Ambati. (2014) Morpholino-Mediated Isoform Modulation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) Reduces Colon Cancer Xenograft Growth. Cancers 6:4, pages 2330-2342.
Crossref
Zheng Fan, Tina Sehm, Manfred Rauh, Michael Buchfelder, Ilker Y. Eyupoglu & Nicolai E. Savaskan. (2014) Dexamethasone Alleviates Tumor-Associated Brain Damage and Angiogenesis. PLoS ONE 9:4, pages e93264.
Crossref
R. Shao, R. Francescone, N. Ngernyuang, B. Bentley, S. L. Taylor, L. Moral & W. Yan. (2013) Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma. Carcinogenesis 35:2, pages 373-382.
Crossref
Roberto Würth, Federica Barbieri & Tullio Florio. (2014) New Molecules and Old Drugs as Emerging Approaches to Selectively Target Human Glioblastoma Cancer Stem Cells. BioMed Research International 2014, pages 1-11.
Crossref
Zhifei Cao, Bingxue Shang, Gaochuan Zhang, Lucio Miele, Fazlul H. Sarkar, Zhiwei Wang & Quansheng Zhou. (2013) Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1836:2, pages 273-286.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.